Double-Digit Growth Expected for Medical Device Reprocessing Market

The global medical device reprocessing market is primed for explosive growth this decade.

Verified Market Research data predicts the sector to grow 15.86 percent annually through 2028 to reach $4.01 billion, nearly quadruple the market’s $1.23 billion value two years ago. Fueling the expansion is increasing demand for low-cost reprocessed medical devices, a reduction in medical waste, and rising number of surgical procedures and other factors. 
 
The primary factor driving the market growth is increasing involvement of medical device reprocessing workflow, trending bio banking scenario, and rise in outsourcing medical instrument reprocessing. The medical device assists in diagnosing, treating, and enhancing the patients’ health. Reprocessing couples with the treatment of materials to make them reusable. Reprocessing is considered cleaning, disinfecting, sterilizing, reconditioning, repairing, and refurbishing medical devices. Demand for the medical device reprocessing market is increasing in both developed and developing countries, with the increasing development of refurbished equipment and services and government initiatives to reduce the use of medical devices. The medical device reprocessing market is growing due to the need to save money as the crisis unfolds and the adaptation increases.
 
There is an increase in demand for medical supplies to care for the infected population. Respiratory support devices like atomizers, life support machines, oxygen generators, and monitors are major medical devices in primary clinical treatment. Also, COVID-19 has increased the demand for medical supplies like personal protective equipment, including masks, gloves, and protective eyeglasses. The need for medical supplies has increased significantly among healthcare professionals and the civil population for preventive measures because of increasing COVID-19 cases across the globe. Manufacturers of these products can capitalize on this increased demand for medical supplies to ensure an adequate and continuous supply of personal protective equipment in the market. Thus, COVID 19 is expected to affect the global medical device reprocessing market significantly.

On May 2019, Medtronic announced the FDA approval and marketing of the Select Site C304-HIS deflectable catheter system. This system is employed in His-bundle pacing processes. This strategic path increased revenue and boosted the company’s standing in the industry.